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Abstract
Introduction: We describe the case of a patient who experienced phantom pain that began 42 years after right
above-the-knee amputation. Immediately prior to phantom pain onset, this long-term amputee had experienced,
in rapid succession, cancer, hemicolectomy, chemotherapy, and thrombotic occlusion. Very little has been
published to date on the association between chemotherapy and exacerbation of neuropathic pain in amputees,
let alone the phenomenon of bringing about pain in amputees who have been pain-free for many decades. While
this patient presented with a unique profile following a rare sequence of medical events, his case should be
recognized considering the frequent co-occurrence of osteomyelitis, chemotherapy, and amputation.
Case presentation: A 68-year-old Australian Caucasian man presented 42 years after right above-the-knee
amputation with phantom pain immediately following hemicolectomy, thrombotic occlusion in the amputated leg,
and chemotherapy treatment with leucovorin and 5-fluorouracil. He exhibited probable hyperalgesia with a
reduced pinprick threshold and increased stump sensitivity, indicating likely peripheral and central sensitization.
Conclusion: Our patient, who had long-term nerve injury due to amputation, together with recent ischemic nerve
and tissue injury due to thrombosis, exhibited likely chemotherapy-induced neuropathy. While he presented with
unique treatment needs, cases such as this one may actually be quite common considering that osteosarcoma can
frequently lead to amputation and be followed by chemotherapy. The increased susceptibility of amputees to
developing potentially intractable chemotherapy-induced neuropathic pain should be taken into consideration
throughout the course of chemotherapy treatment. Patients in whom chronic phantom pain then develops,
perhaps together with mobility issues, inevitably place greater demands on healthcare service providers that
require treatment by various clinical specialists, including oncologists, neurologists, prosthetists, and, most
frequently, general practitioners.
Introduction
Phantom pain in amputees usually emerges immediately
after limb loss and tends to become less troublesome
with time [1]; however, some rare patients exhibit late-
onset phantom pain [2,3]. The patient described in the
present case report began to experience chronic stump
and phantom pain 42 years after the original traumatic
amputation, apparently triggered by later-occurring
hemicolectomy, subsequent thrombotic occlusion in the
amputated limb, and chemotherapy.
Case presentation
Our patient was a 68-year-old Australian Caucasian man
who had a right above-the-knee amputation following a
motorcycle accident in 1959, when he was 19 years of
age. He initially perceived a painless phantom that dissi-
pated soon after amputation. He did not have painful
neuromata, but experienced paroxysmal shock-like
stump pain two to three times yearly that would settle
within 24 hours. We first assessed our patient’sp h a n -
tom pain in a questionnaire study in 2005 [4], three
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recently via an interview and clinical examination in
2009 conducted to investigate his late-onset phantom
pain. The patient provided written, informed consent
for the publication of this case report, and both studies
were approved by local and hospital ethics committees.
In 2002, our patient was diagnosed with moderate to
poorly differentiated adenocarcinoma which had infil-
trated through the full thickness of the bowel wall and
into one regional lymph node. He promptly underwent
right hemicolectomy. Fifteen days later he was diag-
nosed with pulmonary emboli and secondary pneumo-
nia. Thrombotic occlusion had developed in the right
superficial femoral vein approximately 5 cm distal to the
long saphenous junction and extending proximally to
the level of the distal common femoral artery. The
patient was advised against prosthesis use until the
blood clot cleared approximately four months after the
initial surgery.
Our patient completed a six-month course of che-
motherapy with leucovorin 38 mg and 5-fluorouracil (5-
FU) 800 mg, which were administered with domperi-
done 10 mg and dexamethasone 4 mg to 8 mg. There
was no prophylactic administration of vitamin E before
chemotherapy. Little note was made of the effect that
these agents had on our patient’s stump and phantom
pain, except that he was advised to bandage his swollen
stump during the third cycle and he reported nerve pain
in the stump by the sixth cycle. The possible cause of
stump swelling was not recorded.
Our patient noted the presence of a painful phantom
foot, telescoped near the stump, and a definite increase
in stump pain and hyperalgesia, which was particularly
pronounced after prosthesis use, which began during
the course of chemotherapy treatment. He presently
takes carbamazepine (200 mg daily) and tramadol (200
mg daily) to manage his pain. Our patient is unable to
differentiate between his stump and phantom pain, as
they both occur within the same region, often simulta-
neously, and are characterized by the same sensations.
Deep manipulation of the stump (with fingers) now trig-
gers shock-type pains; however, providing even pressure
with the prosthesis helps to alleviate pain, indicating the
absence of any continuing irritation of the stump. The
phantom sometimes feels cold, but never hot or
burning.
Our patient’s pain is exacerbated by sitting, increased
levels of activity, heavy lifting, hot weather, sweating,
and stress. He has never noticed any increase or change
in pain in relation to toileting, having a full bladder or
bowel, or genital stimulation. He finds that walking and
keeping occupied reduces his pain. On the basis of the
McGill Pain Questionnaire [5], he described his pain as
jumping, tingling, aching, intense, numb, cold, and
nagging (see Table 1 for pain intensity and unpleasant-
ness ratings).
On the Leeds assessment of neuropathic symptoms
and signs pain scale [6], our patient scored 7 out of 16,
responding positively to “having pain that feels like
strange sensations in the skin characterised as pricking,
tingling, or pins and needles” and “having pain that
comes on suddenly in bursts for no apparent reason
when he is still.”
The patient did not exhibit allodynia on the stump
when lightly stroked with cotton wool, but exhibited
hyperalgesia and a reduced pinprick threshold in the
stump region (pinprick was rated at 45 out of 100 on
the Visual Analogue Scale (VAS), where a score of 0 is
not painful and a score of 100 is the worst possible
pain), compared to the arm (8 out of 100) and the lower
shin of the intact leg (10 out of 100). The patient’s per-
ception threshold to Von Frey filaments was the same
between his arm, stump, equivalent region on the intact
leg, and lower shin on the intact leg at a pressure of
2.05 g, indicating diminished protective sensation in all
regions. In the stump, 15.00 g was perceived as just
painful (VAS score 15 out of 100). When tested for tem-
poral summation (10 applications of the 15 g filament at
a frequency of 1 second), the patient experienced
marked wind-up, with an increase in pain intensity to
56 out of 100. Given the reduced protective sensations
noted above, such a pattern may be considered sugges-
tive of hyperpathia.
Discussion
The patient described in the present case report experi-
enced late-onset chronic stump and phantom pain after
bowel surgery and chemotherapy with thrombotic occlu-
sion in the amputated leg. He had presented with
reduced pinprick threshold on his stump and dimin-
ished nerve function in all regions. Three mechanisms
may have interacted to initiate and maintain his pain:
Table 1 Intensity and unpleasantness of stump and
phantom pain in 2005 when the patient was first
interviewed and at 2009 follow-up
Level of pain 2005 2009
Stump pain
Intensity (constant)
a 70 25
Intensity during episode of pain
a 70 80
Unpleasantness
b 70 35
Phantom pain
Intensity (constant)
a 60 30
Intensity during episode of pain
a 70 80
Unpleasantness
b 50 35
aRated on a scale where 0 means no pain and 100 means the worst possible
pain;
brated on a scale where 0 means not unpleasant pain and 100 means
intolerable pain.
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induced peripheral neuropathy (CIPN), of which he was
at greater risk considering his recent ischemic obstruc-
tion; and (3) central reorganization due to surgery and
new peripheral nociceptive input from damaged nerves.
Denervation typically triggers reorganization of the
sensory and motor maps of the denervated limb and is
associated with phantom pain [7]. While remapping of
the sensory homunculus occurs soon after amputation
(for example, lower-limb amputation resulting in the
foot representation’s responding to stimulation of the
upper leg or the genitals), over time these patterns can
change. The hemicolectomy itself may potentially have
influenced the leg central nervous system (CNS) repre-
sentation, but this is unlikely because our patient’s pain
was not triggered or exacerbated by bladder or bowel
functioning or by stimulation of “typical” homuncular
regions such as the lower back or hip.
Thrombotic occlusion and ischemia can cause neuro-
pathic complications, and vascular mechanisms such as
decreased blood flow and cooler stump temperatures are
associated with increased phantom pain [8]. Amputees
with blood clot etiology experience exacerbated phantom
pain and higher cutaneous pain thresholds, suggesting
that thrombosis and associated nerve injury have a
unique effect on pain generation and perception [9].
Patients with phantom pain exhibit greater sympathetic
responses to personal stressors, with cardiovascular over-
reactivity and increased heart rate and systolic blood
pressure, which are also consistent with the circum-
stances in the present case, in which our patient experi-
enced heightened pain during increased autonomic and
emotional arousal. The triggers of our patient’s phantom
pain indicate possible autonomic nervous system involve-
ment and warrant further investigation.
CIPN is experienced by up to 50% of cancer survivors
and is more common among those with pre-existing
peripheral neuropathy, such as amputation [10] or per-
ipheral neuropathy [11], even when these patients are
given “safe” treatment doses [12]. Degeneration of the
peripheral nerves, particularly in patients with pre-exist-
ing neuropathy, may cause irreversible changes in pain
gating through the dorsal and ventral horns, leading to
altered central pain processing. While 5-FU, with which
our patient was treated, is not typically identified as
causing CIPN, there are at least two prior case reports
of 5-FU-induced neuropathy [13,14]. Our patient pre-
sented with general diminished protection at all periph-
eral regions, possibly due to age-related degenerative
processes or to the rare occurrence of 5-FU-induced
sensorimotor axonal neuropathy.
The pain system changes dynamically in response to
ongoing activation. Nerves severed by amputation or
injured through CIPN or vascular occlusion generate
high rates of ectopic activity, resulting in paroxysmal
neuropathic pain [15], which is consistent with our
patient’s pain. He had increased pain sensitivity and
excitability of the peripheral nerve fibers, particularly
the A-fibers as indicated by punctate hyperalgesia [16],
in the stump following chemotherapy. Damage to the
peripheral nerves may have caused increased sensitivity
of neurons in the dorsal horn and supra-spinal regions,
resulting in central sensitization [17], eventuating in the
perception of chronic phantom pain. The clinical exami-
nation also indicated hyperpathia in our patient, which
is thought to be a CNS disorder following central
deafferentation.
Conclusions
In summary, in the present case, the patient experienced
late-onset phantom pain 42 years following amputation.
The rare combination of hemicolectomy, venous throm-
bosis, pulmonary emboli, anticoagulation, and che-
motherapy with 5-FU and leucovorin likely caused a
sequence of neuronal changes that resulted in the
patient’s perception of chronic and troublesome phan-
tom and stump pain. This case highlights that even a
previously modified CNS following amputation retains
neuroplasticity in response to a new assault, with the
capacity to awaken a sleeping phantom that is character-
ized by bothersome chronic pain. Indeed, our patient
first experienced phantom pain many years after ampu-
tation, even though the initial injury did not result in
such pain. Ultimately, these mechanisms must be con-
sidered in cancer treatment of amputees and patients
with pre-existing neuropathy.
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